GL1X · GenesisL1 explorer

MolNFT v1 · #93844 · protein

Clostridium botulinum serotype a light chain inhibited by adamantane hydroxamate

4HEV · Botulinum neurotoxin type a light chain: “Clostridium botulinum serotype a light chain inhibited by adamantane hydroxamate”. X-ray diffraction, 2 ligands (AXM, ZN), 9 pockets (best druggability 0.77). MolNFT v1 #93844 on GenesisL1…

PDB
4HEV
Type
protein
Length
790 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a light chain
EC
3.4.24.69
UniProt
P10845
Ligands
AXM, ZN
Pockets
9 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a light chain (EC 3.4.24.69)protein39732% helix, 16% strandP10845
BBotulinum neurotoxin type a light chain (EC 3.4.24.69)protein39331% helix, 17% strandP10845

Ligands and binding sites

  • AXM · N-hydroxy-2-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]acetamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19220.770.7966empty
22370.630.8230AXM
32560.620.8135ZN, AXM
41800.550.8028empty
51710.540.8027empty

Interfaces

1 interface between chains.

  • A–B · 1828 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4HEV · Clostridium Botulinum Serotype A Light Chain Inhibited By Adamantane Hydroxamate · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.